PayerWatch

From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation 02.04.2026 35:44 ↓

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians spend nearly two business days...

Turning Denial Data Into Action: How Healthcare Organizations Can Fight Back Against Payer Denials 06.03.2026 24:57 ↓

Healthcare providers across the U.S. are facing a growing wave of claim denials that is putting pressure on already strained hospital finances. Industry research from the American Hospital Association shows that nearly 15% of medical claims submitted to private payers are initially denied, forcing hospitals and health systems to spend about $19.7 billion annually attempting to overturn those denia...

Inside ERISA Denials: Why Employers May Be the Real Decision-Makers Behind Your Insurance Card Video 02.12.2025 21:11 ↓

Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered through self-funded employer plans governed by ERISA, which shifts t...